CoChat

Secondary adrenal insufficiency: from the physiopathology to the possible role of modified-release hydrocortisone treatment

Paragliola, Rosa M., Corsello, Salvatore M. · 2018 · Minerva Endocrinology

The DOI matches its Crossref record.

Abstract

Central adrenal insufficiency (AI) represents a life-threatening disorder that results from a reduced cortisol production due to an impairment production of adrenocorticotropic hormone (ACTH). In particular, secondary AI results from pituitary disease that impedes the release of ACTH, while tertiary AI is caused from an impaired synthesis of corticotropin-releasing hormone. Central AI has an estimated prevalence of 150-280 per million, resulting more common than primary AI. Prompt diagnosis and management of this condition is crucial, but the diagnostic investigation can often be challenging, in particular in cases of recent onset of secondary adrenal insufficiency. Moreover, different formulations of steroid replacement therapy are available for both primary and central adrenal insufficiency, but the therapy of choice for the treatment of secondary hypoadrenalism is still debated. In particular, several data confirm the advantages of dual-release hydrocortisone formulation in primary hypoadrenalism, while data for secondary AI are still lacking. However, in spite of few clinical data, the use of dual release hydrocortisone can be extremely favorable in ACTH deficiency, which is associated with an increase of overall and cardiovascular mortality, also due to the risk of overtreatment. In this condition, the use of a modified-release glucocorticoid formulation, which has been demonstrated to improve metabolic profile, can be extremely attractive.

Overview

Integrity signals

Registry

Crossref · 10.23736/s0391-1977.17.02701-8

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 30

Metadata

Authors
Paragliola, R. M., & Corsello, S. M.
Affiliations
Università Cattolica del Sacro Cuore (IT)
Venue
Minerva Endocrinology
Published
2018-05
Volume
43
Issue
2
Pages
183-197
ISSN
  • 0391-1977 (ISSN-L)
  • 2724-6507
  • 2724-6116
OpenAlex
W2953797681
Cited by
23
References
0
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 4
FWCI
1.99
Type
journal article
Language
en
Open access
closed
Locations
  • Minerva Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords
secondary adrenal insufficiency, ACTH deficiency, cortisol, steroid replacement therapy, pituitary disorders, corticotropin-releasing factor, overtreatment, cardiovascular mortality, metabolic profile
MeSH terms
Adrenal Insufficiency, Adrenocorticotropic Hormone, Delayed-Action Preparations, Humans, Hydrocortisone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Secondary adrenal insufficiency: from the physiopathology to the possible role of modified-release hydrocortisone treatment. https://app.cochat.ai/papers/10.23736/s0391-1977.17.02701-8
The paper
Paragliola, R. M., & Corsello, S. M. (2018). Secondary adrenal insufficiency: from the physiopathology to the possible role of modified-release hydrocortisone treatment. Minerva Endocrinology. https://doi.org/10.23736/s0391-1977.17.02701-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.